Dr. Ohkawa is a member of the Takeda Board of Directors and previously was the General Manager of the Pharmaceutical Research Division. Dr. Ohkawa has been with Takeda for 30 years.
Hiroyuki Odaka, Ph.D., will replace Dr. Ohkawa as General Manager, Pharmaceutical Research Division. Dr. Odaka joined Takeda in 1982 and most recently has been Director of Pharmacology Research Laboratory 1.
Tetsuo Miwa, Ph.D. will become General Manager, CMC Center. Dr. Miwa joined Takeda in 1985 and has held a number of leadership roles in Takeda's research organization, including Director of Discovery Research Center. Most recently, Dr. Miwa belonged to Strategic Product Planning and was in charge of cross-franchise portfolio management and the Millennium acquisition and transition.
Nancy Joseph-Ridge, M.D., will replace Dr. Masaomi Miyamoto as General Manager, Pharmaceutical Development Division. Dr. Joseph-Ridge is currently President of Takeda Global Research & Development Center, Inc., U.S., and will retain this position until her replacement has been announced. She was previously with TAP Pharmaceutical Products Inc.
Yoichi Okumura, will continue in his role as General Manager of Intellectual Property Department. Mr. Okumura joined Takeda in 1984 and has been General Manager of IP Department since 2007.
To ensure further global optimization of the company's pharmaceutical development functions, the global development headquarter functions will be moved to Takeda's Deerfield, Illinois headquarters in the United States, with the transfer anticipated to be complete by July 1. Previously, the Takeda Group's headquarters for development were based in Osaka, Japan, and Takeda managed global development through its regional hubs in Japan, the United States, Europe and a recently est
|SOURCE Takeda Pharmaceutical Company Limited|
Copyright©2009 PR Newswire.
All rights reserved